Jean-Baptiste-Édouard Gélineau

Jean-Baptiste-Édouard Gélineau

Jean-Baptiste-Édouard Gélineau (23 December 1828 – 2 March 1906) was the French physician who first described narcolepsy.

Gélineau was born in Blaye, Gironde, and had a varied life. As a young student at the Rochefort Navy Medical School he took part in the combat against cholera, from which the city of La Rochelle was suffering. In 1849 he became an intern of the Navy Hospital and in the following year a "Surgeon of the Third Class".

As a Navy surgeon he visited French colonies in the Indian Ocean: first Réunion island and then Mayotte in the Comoros archipelago. During this period he wrote Voyage a i'lle de la Réunion, a memoir published much later, in 1905, in which he described colonial life and the abolition of slavery. He included the story of Elise, a beautiful Creole woman. She was the concubine of a young naval commander, and had a child who died soon after birth. This indicates the autobiographic character of the work.

He defended a doctoral thesis "Aperçu Medical de I'lle de Mayotte" at Montpellier University School of Medicine in 1858, using the data collected during his year-and-a-half stay on Mayotte. At that time he was a "Navy Surgeon of the Second Class".

For his dedication in fighting epidemics that broke out during the Franco-German war in 1870, he was nominated for the Legion of Honor, but received it later on. He also held the Officier d'Academie and Commander of Nichan of the Ottoman Empire.

In 1871, Gélineau introduced "Doctor Gélineau's Tablets" for the treatment of epilepsy (they contained bromide and arsenic). He was a member of the Société de Médicine, Société d' Hypnologie, La Société Française d' Hygiène, and a few others.

After retirement at the age of 72, Gélineau switched to wine production, continuing the family tradition. He was awarded gold medals at exhibitions in Antwerp and Paris. He died, aged 77, in Argelès-Gazost, Pyrenees.

References


This article is issued from Wikipedia - version of the 3/30/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.